Does Dr. PANAMBUR LAXMINARAYA BHANDARI have financial conflicts of interest?

Dr. PANAMBUR LAXMINARAYA BHANDARI (M.D.) has received a total of $876 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $876 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. PANAMBUR LAXMINARAYA BHANDARI?

According to CMS Open Payments data, Dr. PANAMBUR LAXMINARAYA BHANDARI received funding from ENDO PHARMACEUTICALS ($180), BONE SUPPORT ($154), and CHECKPOINT SURGICAL ($153).

Does Dr. PANAMBUR LAXMINARAYA BHANDARI receive research grants or speaking fees?

Dr. PANAMBUR LAXMINARAYA BHANDARI has received $876 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. PANAMBUR LAXMINARAYA BHANDARI

M.D.Real-Time Hydrated

Specialty: Surgery, Plastic and Reconstructive Surgery

Practice Location: NASHVILLE, TN 37232

NPI Number: 1326493461

LIFETIME INDUSTRY VALUE

$876

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BHANDARI is a verified Surgery, Plastic and Reconstructive Surgery practitioner based in NASHVILLE, TN.

Between 2021 and 2025, Dr. BHANDARI had an overall industry promotional and research financial footprint of $876 as recorded in the federal CMS Open Payments database.

$876 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BHANDARI's primary funding source is ENDO PHARMACEUTICALS, which accounts for $180 (representing 20.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ENDO PHARMACEUTICALS

Rank 1

$180

20.5%

BONE SUPPORT

Rank 2

$154

17.5%

CHECKPOINT SURGICAL

Rank 3

$153

17.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.